|
Khalilov M.A., Moshkin A.S., Moshkina L.V., Shmeleva S.V., Tuzov I.N., Belyakova N.V., Khromov S.E.
The impact of individual characteristics of the carotid arteries and heart on disease development
|
№6 / 2025
|
|
M.V. Leonova
The role of tadalafil and sildenafil in reducing the risk of cardiovascular outcomes
|
№4 / 2025
|
|
S.A. Derbeneva, S.V. Shmeleva, S.B. Kachalov, L.V. Elgarova
Evaluation of the effectiveness of diet therapy enriched with insoluble dietary fibers in patients with hyperlipoproteinemia
|
№1 / 2025
|
|
O.D. Ostroumova, S.V. Litvinova, N.A. Plotnikova, A.I. Kochetkov, A.V. Arablinsky, S.S. Eremina
Known and little-known facts about acetylsalicylic acid
|
№1 / 2025
|
|
Sharonova L.A., Bulgakova S.V., Dolgikh Yu.A., Kosareva O.V., Merzlova P.Ya., Treneva E.V., Kurmaev D.P.
Extraosseous symptoms of primary hyperparathyroidism in the practice of a general practitioner
|
№8 / 2024
|
|
Trofimenko I.N., Chernyak B.A.
Modern possibilities of bronchodilation therapy for patients with chronic obstructive pulmonary disease
|
№1 / 2024
|
|
Leonova M.V.
Polypills in the fight against cardiovascular diseases: a modern review of effectiveness
|
№1 / 2024
|
|
M.V. Leonova
Bempedoic acid – a new drug in lipid-lowering therapy
|
№14 / 2023
|
|
E.V. Biryukova, M.V. Shinkin, I.A. Morozovа
Modern practice of lipid-lowering pharmacotherapy: the choice of the optimal fixed combination
|
№3 / 2023
|
|
O.A. Polyakova, Yu.M. Tkachenko, O.D. Ostroumova
Relationship between non-alcoholic fatty liver disease and cardiovascular disease: focus on the use of ursodeoxycholic acid
|
№1-2 / 2023
|
|
A.F. Verbovoy, N.I. Verbovaya, L.A. Sharonova
Hypothyroidism is an untimely diagnosed disease
|
№11-12 / 2022
|
|
M.S. Novikova, O.M. Koteshkova, M.B. Antsiferov
Efficacy and safety of ertugliflozin: results of the VERTIS CV sub-study in patients receiving a stable dose of insulin
|
№4 / 2022
|
Русский
